# A Multicenter Study to Evaluate the Effect of High Dose Rosuvastatin Versus Rosuvastatin and Ezetimibe in Stroke

> **NCT05884502** · PHASE4 · UNKNOWN · sponsor: **Korea University Anam Hospital** · enrollment: 330 (estimated)

## Conditions studied

- Dyslipidemias
- Stroke, Acute Ischemic

## Interventions

- **DRUG:** combination of high-dose rosuvastatin and ezetimibe
- **DRUG:** high-dose rosuvastatin single administration

## Key facts

- **NCT ID:** NCT05884502
- **Lead sponsor:** Korea University Anam Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 330 (ESTIMATED)
- **Last updated:** 2023-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05884502

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05884502, "A Multicenter Study to Evaluate the Effect of High Dose Rosuvastatin Versus Rosuvastatin and Ezetimibe in Stroke". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05884502. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*